Are you Dr. Thomas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1230 Baxter St
Athens, GA 30606Phone+1 706-548-7581
Summary
- Dr. Bobby Thomas, MD is a board certified radiologist in Athens, Georgia. He is currently licensed to practice medicine in Georgia. He is affiliated with St. Mary's Health Care System and Piedmont Athens Regional Medical Center.
Education & Training
- Emory University School of MedicineFellowship, Neuroradiology, 1979 - 1980
- Emory University School of MedicineResidency, Radiology-Diagnostic, 1975 - 1976
- University of Florida College of Medicine JacksonvilleResidency, Radiology-Diagnostic, 1974 - 1974
- New Hospital Lutheran HospitalInternship, Transitional Year, 1973 - 1973
- Christian Medical College VelloreClass of 1972
Certifications & Licensure
- GA State Medical License 1976 - 2015
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 36 citationsBach1 derepression is neuroprotective in a mouse model of Parkinson's disease.Manuj Ahuja, Navneet Ammal Kaidery, Otis C. Attucks, Erin McDade, Dmitry M. Hushpulian
Proceedings of the National Academy of Sciences of the United States of America. 2021-11-09 - 2 citationsIdentification of a potent Nrf2 displacement activator among aspirin-containing prodrugsIrina N. Gaisina, Dmitry M. Hushpulian, Arsen Gaisin, Eliot H. Kazakov, Navneet Ammal Kaidery
Neurochemistry International. 2021-07-27 - 19 citationsChallenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue.Dmitry M. Hushpulian, Navneet Ammal Kaidery, Manuj Ahuja, Andrey A. Poloznikov, S. Sharma
Frontiers in Aging Neuroscience. 2021-04-08
Press Mentions
- Metabolite of Multiple Sclerosis Drug Could Be Safe, Effective Therapy for Parkinson's DiseaseDecember 27th, 2016